ArticleTheranostics2021

Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy.

Szu-Jung Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.